Earnings Insights

AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.

How to use these insights

Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.

Sudeep Pharma Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Excluding battery materials, business can scale up to approximately INR 1000-1200 crores revenue without additional capex. Key concall takeaways from Sudeep…

31 May 2026

Le Travenues Technology Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Trains**: Maintained market share (~62%) but faced volume compression due to structural/policy changes; growth to be stable, with mild share increases. Key…

31 May 2026

Blue Jet Healthcare Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

For contrast media, the increase in revenue to INR190 crores in Q4 belongs entirely to the order book for that quarter, with normalized goods in transit. Key…

31 May 2026

Aditya Birla Fashion & Retail Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

TMRW business is experiencing strong growth trajectory with over 25%-30% growth, driven by superior execution, brand building, and growth capital infusion. Key…

31 May 2026

Power Mech Projects Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

MDO revenues to increase from INR 226 crores in Q4 FY26 to INR 500 crores in FY27 and INR 1,250 crores in FY28. Key concall takeaways from Power Mech Projects…

31 May 2026

Star Cement Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Capex is planned aggressively with INR600-700 crores in FY27 and INR1,500 crores in FY28 to support growth and commissioning of plants starting around H1 FY29…

31 May 2026

Amagi Media Labs Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Revenue grew 30% to INR 1,506 crores in FY26, with a 23% constant currency growth; Q4 grew about 29% (Page 4). Key concall takeaways from Amagi Media Labs…

31 May 2026

Karnataka Bank Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

As of March, Karnataka Bank had ₹2,000 crores of sanctioned loans pending disbursal. Key concall takeaways from Karnataka Bank's Q4 FY26 earnings call — and…

31 May 2026

Honasa Consumer Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Younger brands are growing strongly, with growth rates near 40% including acquisitions. Key concall takeaways from Honasa Consumer Ltd's Q4 FY26 earnings call…

31 May 2026

Jubilant Ingrevia Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

3,500 crore potential in CDMO, including phased growth (20-25% peak revenue in Year 1, 50-60% in Year 2, 80%+ in Year 3). Key concall takeaways from Jubilant…

31 May 2026

Whirlpool of India Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

. Key concall takeaways from Whirlpool of India Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

31 May 2026

Minda Corporation Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Lifetime order book stands at INR 10,000 crores with execution timelines generally between 48 to 60 months, suggesting steady revenue visibility. Key concall…

31 May 2026

Happy Forgings Q4 FY26: Capex ₹460 Cr | Arthneeti

Q4 FY26

950 crores. Key concall takeaways from Happy Forgings Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

31 May 2026

Vinati Organics Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

FY26 growth was similar to FY25, around 5%. Key concall takeaways from Vinati Organics Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

31 May 2026

Engineers India Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Typical order conversion rate from pipeline is about 20%-25%. Key concall takeaways from Engineers India Ltd's Q4 FY26 earnings call — and how it ranks against…

31 May 2026

Dr Agarwals Health Care Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Overall volume growth in FY '26 was ~7%, value (realization) growth also ~7%, indicating balanced growth. Key concall takeaways from Dr Agarwals Health Care…

31 May 2026

Jubilant Pharmova Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Ruby-Fill® revenue continuing rapid expansion (~30%+ growth), with increasing market size, share, and pricing. Key concall takeaways from Jubilant Pharmova…

31 May 2026

Sansera Engineering Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Strong order book visibility close to INR8,000-8,200 crores for execution in next 2-3 years. Key concall takeaways from Sansera Engineering Ltd's Q4 FY26…

31 May 2026

Poly Medicure Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

Management confident of 15-17% sustainable organic growth over next 3-5 years excluding acquisitions. Key concall takeaways from Poly Medicure Ltd's Q4 FY26…

31 May 2026

Vertis Infrastructure Trust Q4 FY26 earnings call: Revenue & Margins | Arthneeti

Q4 FY26

The 7-year CAGR traffic growth stands at 7.2%, reflecting consistent long-term volume expansion. Key concall takeaways from Vertis Infrastructure Trust's Q4…

31 May 2026

Arthneeti Pro · Annual

Every earnings call this season,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access